glp-1 masld Why are agonists being used to treat patients with nonalcoholic fatty liver disease? Emerging Role of GLP-1 Receptor

Glucose-dependent insulinotropic polypeptide prevents the progression of macrophage-driven atherosclerosis in diabetic apolipoprotein E-null mice

Clinicians may monitor side effects, hydration, food intake, weight trends, and treatment response

Beyond weight loss, GLP-1 RAs show promise for cardiovascular disease, dementia prevention, mast cells, and immune conditions

The TRIUMPH-1 readout has not yet appeared in a peer-reviewed journal

But Noom's microdoses of motivation and microdosed GLP-1s can help. The ad -- and another Wilson spot -- end with the line Micro changes, big results

Last reviewed: May 14, 2026 Last updated: May 14, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations